This inventor holds 35 USPTO granted patents and 16 published patent applications and 7 EPO patents, primarily in Gene Therapy Vectors. Top assignees: University of Florida Research Foundation Inc., The University of North Carolina at Chapel Hill, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2011-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
32 out of 3,058 
6 out of 1,330 
2 out of 3,699 
Years Active: 2011-2026
Areas of Expertise:
Title: Mavis Agbandje-McKenna: Pioneering Innovations in Gene Therapy
Introduction
Mavis Agbandje-McKenna is a distinguished inventor based in Gainesville, Florida, with an impressive portfolio of 31 patents. Her groundbreaking work in the field of virology and gene therapy has significantly contributed to advancements in medical science.
Latest Patents
Among her latest inventions are the **AAV chimeras** and **high-transduction-efficiency rAAV vectors, compositions, and methods of use**. The AAV chimeras involve innovative compositions and methods for packaging a recombinant adeno-associated virus (rAAV) particle, utilizing inverted terminal repeats (ITRs) and rep genes from various serotypes. Additionally, her work on high-transduction-efficiency rAAV vectors includes modifications to the capsid proteins that enhance the transduction efficiency across different types of cells, tissues, and organs, surpassing the performance of wild-type rAAV vectors.
Career Highlights
Mavis has held significant positions at notable institutions, including the University of Florida Research Foundation and the University of North Carolina at Chapel Hill. Her career illustrates a dedication to research that bridges theoretical knowledge and practical application, leading to impactful innovations that are poised to revolutionize gene therapies.
Collaborations
Throughout her career, Mavis has collaborated with esteemed colleagues such as Arun Srivastava and Li Zhong. These partnerships have fostered a rich exchange of ideas and expertise, propelling advancements in their shared field of molecular biology and genetic engineering.
Conclusion
Mavis Agbandje-McKenna continues to be a leading figure in her field, with patents that reflect her commitment to innovation and excellence in research. Her contributions not only enhance our understanding of gene therapy but also pave the way for future breakthroughs in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile